Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
Frank Rosenbauer, Katharina Wagner, Jeffery Lorne Kutok et al. · Nature Genetics · 2004
Cited by 506 works. doi:10.1038/ng1361
Authors
- Frank Rosenbauer
- Katharina Wagner
- Jeffery Lorne Kutok
- Hiromi Iwasaki
- Michelle M. Le Beau
- Yutaka Okuno
- Koichi Akashi
- Steven Fiering
- Daniel Geoffrey Tenen
References
- The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
- A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
- Acre-transgenic mouse strain for the ubiquitous deletion ofloxP-flanked gene segments including deletion in germ cells
- Requirement of Transcription Factor PU.1 in the Development of Multiple Hematopoietic Lineages
- Reversible Tumorigenesis by MYC in Hematopoietic Lineages
- An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination
- Myc Function and Regulation
- Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities.
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia